Using of Testes Shocker in Improving the Spermatogenesis and Sperms Activity

Not Applicable

Recruiting

• Conditions: Infertility Unexplained; Infertility Due to Complete Spermatogenic Arrest; Oligospermia; Asthenozoospermia; Necrospermia; Infertility, Male

• Registration Number: NCT05506722
• Lead Sponsor: University of Baghdad

Brief Summary

Infertility was reported in approximately 15% of all heterozygous couples, with male factor accounting for nearly half the cases. This typically occurs due to low sperm production, sperm dysfunction, and sperm delivery obstruction. Etiology of male infertility can be attributed to many factors including acute or chronic illness, accidents, and lifestyle choices.

Detailed Description

This study demonstrated that using a painless, convenient at-home device could significantly improve sperm motility and count. This device can be utilized to tackle (for unexplained infertility) the significant issue of infertility in a cost-effective, safe and efficacious.

Study Timeline

• Study First Submitted: 2022-08-17
• Study First Submitted QC: 2022-08-17
• Study First Posted: 2022-08-18
• Study Start: 2022-09-01
• Status Verified: 2022-10
• Last Update Submitted: 2022-10-31
• Last Update Posted: 2022-11-03
• Primary Completion: 2023-01-01
• Study Completion: 2023-01-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: Male
• Target Recruitment: 250

Inclusion Criteria

• Infertile male with oligosperma, necrospermia, asthenozoospermia or hypospermia. Must not taking any drugs or medications for infertility and has nit any congenital diseases in the genital tracts or chronic diseases.

Exclusion Criteria

• Have congenial genital tract disease, has a chrome disease, has other than the above mentioned causes for infertility or taking medications that can affect the fertility.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Semen analysis	4 months	By taking the semen from the participants at baseline and then after each month and analyse it.

Trial Locations

Locations (1)

Al-Dar medical Center; 🇮🇶 Nasiriyah, Thi Qar, Iraq